.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Express Scripts
Fuji
US Army
Cipla
Teva
Novartis
Chinese Patent Office
Merck
AstraZeneca

Generated: June 26, 2017

DrugPatentWatch Database Preview

PAMINE FORTE Drug Profile

« Back to Dashboard

Which patents cover Pamine Forte, and when can generic versions of Pamine Forte launch?

Pamine Forte is a drug marketed by Fougera Pharms and is included in one NDA.

The generic ingredient in PAMINE FORTE is methscopolamine bromide. There are seven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the methscopolamine bromide profile page.

Summary for Tradename: PAMINE FORTE

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Bulk Api Vendors: see list27
Clinical Trials: see list50
Patent Applications: see list373
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PAMINE FORTE at DailyMed

Pharmacology for Tradename: PAMINE FORTE

Drug ClassAnticholinergic
Mechanism of ActionCholinergic Antagonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms
PAMINE FORTE
methscopolamine bromide
TABLET;ORAL008848-002Mar 25, 2003DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Covington
Cipla
McKinsey
Daiichi Sankyo
Baxter
Chubb
US Department of Justice
Cerilliant
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot